about
Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytesVogt-Koyanagi-Harada syndrome - current perspectives.New biologic-response modifiers in ocular inflammatory disease: beyond anti-TNF treatment.Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Rituximab in refractory Vogt-Koyanagi-Harada disease.
@ast
Rituximab in refractory Vogt-Koyanagi-Harada disease.
@en
type
label
Rituximab in refractory Vogt-Koyanagi-Harada disease.
@ast
Rituximab in refractory Vogt-Koyanagi-Harada disease.
@en
prefLabel
Rituximab in refractory Vogt-Koyanagi-Harada disease.
@ast
Rituximab in refractory Vogt-Koyanagi-Harada disease.
@en
P2093
P2860
P1476
Rituximab in refractory Vogt-Koyanagi-Harada disease.
@en
P2093
Manuel Díaz-Llopis
Roberto Gallego-Pinazo
Rosa Dolz-Marco
P2860
P2888
P304
P356
10.1007/S12348-011-0027-9
P577
2011-07-09T00:00:00Z